Document is current
Any future updates will be listed below
-
Authors
Ryu, Alexander J. https://orcid.org/0000-0002-0138-5112
Kumar, Shaji https://orcid.org/0000-0001-5392-9284
Dispenzieri, Angela https://orcid.org/0000-0001-8780-9512
Kyle, Robert A.
Rajkumar, S. Vincent https://orcid.org/0000-0002-5862-1833
Kingsley, Thomas C.
- License Information
-
More Information
Article History
Received: 10 October 2022
Revised: 1 February 2023
Accepted: 6 February 2023
First Online: 17 February 2023
Competing interests
: AJR, SVR, and TCK report no competing interests. AD reports competing for interests of Janssen advisory board and independent review committee, Oncopeptides and Sorrento data monitoring safety committee, and research funding from Alynlam, Pfizer, Takeda, and Bristol Myers Squibb.
